newsfilter
← Latest News
GlobeNewswire·

180 Life Sciences Provides Update Regarding Anti-TNF Frozen Shoulder Trial

PALO ALTO, Calif., Feb. 22, 2023 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences" or the "Company"), today announced closure to recruitment of men and women across England with early stage